{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:44:27Z","timestamp":1792788267441,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The project is funded by the Foundation of Science Technology Department of Zhejiang Province","award":["LKLZ26H080001"],"award-info":[{"award-number":["LKLZ26H080001"]}],"id":[{"id":"https:\/\/ror.org\/05yj3y977","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2025A1515011491"],"award-info":[{"award-number":["2025A1515011491"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-05115-5","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:43:52Z","timestamp":1790484232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ultrasound-activated Cu2\u2212XSe\/TiO2 heterostructured nanosonosensitizer enables coordinated induction of ferroptosis and cuproptosis for tumor immunotherapy"],"prefix":"10.1186","volume":"24","author":[{"given":"Shibing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meili","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,27]]},"reference":[{"issue":"52","key":"5115_CR1","doi-asserted-by":"publisher","first-page":"2410841","DOI":"10.1002\/adfm.202410841","volume":"34","author":"W Xiong","year":"2024","unstructured":"Xiong W, Cheng Z, Chen H, Liang H, Wang M, Chen Y, et al. Biomimetic tumor cell membrane-encapsulated nanoparticles combine NIR-II photothermal therapy and chemotherapy for enhanced immunotherapy in triple-negative breast cancer. Adv Funct Mater. 2024;34(52):2410841.","journal-title":"Adv Funct Mater"},{"issue":"8","key":"5115_CR2","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1080\/15548627.2025.2479995","volume":"21","author":"D Chen","year":"2025","unstructured":"Chen D, Chen X, Yang M, Li Q, Weng S, Kou S, et al. H3K36me2 methyltransferase NSD2\/WHSC1 promotes triple-negative breast cancer metastasis via activation of ULK1-dependent autophagy. Autophagy. 2025;21(8):1824\u201342.","journal-title":"Autophagy"},{"key":"5115_CR3","doi-asserted-by":"publisher","first-page":"114716","DOI":"10.1016\/j.jconrel.2026.114716","volume":"392","author":"H Wang","year":"2026","unstructured":"Wang H, Ma K, Li Z, Lou S, Yang D, Zhang H, et al. Augmenting cuproptosis and anti-metastatic immunity in breast cancer by copper-based nanoplatform for synergistic immunotherapy via lactate metabolic reprogramming and hypoxia alleviation. J Control Release. 2026;392:114716.","journal-title":"J Control Release"},{"issue":"1","key":"5115_CR4","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1038\/s41467-024-46961-x","volume":"15","author":"F Lynce","year":"2024","unstructured":"Lynce F, Mainor C, Donahue RN, Geng X, Jones G, Schlam I, et al. Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study. Nat Commun. 2024;15(1):2691.","journal-title":"Nat Commun"},{"key":"5115_CR5","doi-asserted-by":"publisher","first-page":"e071674","DOI":"10.1136\/bmj-2022-071674","volume":"381","author":"RA Leon-Ferre","year":"2023","unstructured":"Leon-Ferre RA, Goetz MP. Advances in systemic therapies for triple negative breast cancer. BMJ. 2023;381:e071674.","journal-title":"BMJ"},{"issue":"5","key":"5115_CR6","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1016\/j.apsb.2025.03.004","volume":"15","author":"Y Ou","year":"2025","unstructured":"Ou Y, Zhang K, Shuai Q, Wang C, Hu H, Cao L, et al. USP51\/GRP78\/ABCB1 axis confers chemoresistance through decreasing doxorubicin accumulation in triple-negative breast cancer cells. Acta Pharm Sin B. 2025;15(5):2593\u2013611.","journal-title":"Acta Pharm Sin B"},{"issue":"27","key":"5115_CR7","doi-asserted-by":"publisher","first-page":"2314309","DOI":"10.1002\/adma.202314309","volume":"36","author":"M Meng","year":"2024","unstructured":"Meng M, Wu J, Feng Y, Lin L, Chen J, Pang X, et al. A comprehensive strategy based on high clinical translational nanosystem for programmable immunotherapy of triple negative breast cancer. Adv Mater. 2024;36(27):2314309.","journal-title":"Adv Mater"},{"issue":"41","key":"5115_CR8","doi-asserted-by":"publisher","first-page":"36323","DOI":"10.1021\/acsnano.5c09413","volume":"19","author":"D Chang","year":"2025","unstructured":"Chang D, Yang J, Li Y, Min S, Ma Y, Xu T, et al. Spatiotemporally controlled nanomicelles for synergistic phototherapy and immune reprogramming in triple-negative breast cancer. ACS Nano. 2025;19(41):36323\u201341.","journal-title":"ACS Nano"},{"issue":"52","key":"5115_CR9","doi-asserted-by":"publisher","first-page":"2411247","DOI":"10.1002\/adfm.202411247","volume":"34","author":"Z Li","year":"2024","unstructured":"Li Z, He S, Xie L, Zeng G, Huang J, Wang H, et al. Boosting ferroptosis and immunotherapy for colorectal cancer by lactate-related metabolic reprogramming. Adv Funct Mater. 2024;34(52):2411247.","journal-title":"Adv Funct Mater"},{"issue":"20","key":"5115_CR10","doi-asserted-by":"publisher","first-page":"e14318","DOI":"10.1002\/advs.202514318","volume":"13","author":"Z Li","year":"2026","unstructured":"Li Z, Jiang J, Zhou Y, Mao X, Wen H, Chen Z, et al. Inulin-based oral chemotherapy modulates gut microbiota and immune microenvironment through inhibition of neutrophil extracellular trap formation for improving cancer therapy. Adv Sci (Weinh). 2026;13(20):e14318.","journal-title":"Adv Sci (Weinh)"},{"key":"5115_CR11","doi-asserted-by":"publisher","first-page":"114075","DOI":"10.1016\/j.jconrel.2025.114075","volume":"386","author":"Z Li","year":"2025","unstructured":"Li Z, Chen H, Wang C, Deng T, Huang J, Ye H, et al. Augmenting cGAS\/STING-mediated innate immunity by copper-based nanoplatform for synergistic cancer immunotherapy via inducing irreversible DNA damage. J Control Release. 2025;386:114075.","journal-title":"J Control Release"},{"issue":"1","key":"5115_CR12","doi-asserted-by":"publisher","first-page":"9723","DOI":"10.1038\/s41467-024-54081-9","volume":"15","author":"C Mao","year":"2024","unstructured":"Mao C, Deng F, Zhu W, Xie L, Wang Y, Li G, et al. In situ editing of tumour cell membranes induces aggregation and capture of PD-L1 membrane proteins for enhanced cancer immunotherapy. Nat Commun. 2024;15(1):9723.","journal-title":"Nat Commun"},{"key":"5115_CR13","doi-asserted-by":"publisher","first-page":"101441","DOI":"10.1016\/j.mtbio.2024.101441","volume":"30","author":"N Cheng","year":"2025","unstructured":"Cheng N, Zhou Q, Jia Z, Mu Y, Zhang S, Wang L, et al. Functionalized biomimetic nanoparticles loaded with salvianolic acid B for synergistic targeted triple-negative breast cancer treatment. Mater Today Bio. 2025;30:101441.","journal-title":"Mater Today Bio"},{"issue":"34","key":"5115_CR14","doi-asserted-by":"publisher","first-page":"23727","DOI":"10.1021\/acsnano.4c08613","volume":"18","author":"W Sun","year":"2024","unstructured":"Sun W, Wang H, Qi Y, Li M, Zhang R, Gao Z, et al. Metal-phenolic vehicles potentiate cycle-cascade activation of pyroptosis and cGAS-STING pathway for tumor immunotherapy. ACS Nano. 2024;18(34):23727\u201340.","journal-title":"ACS Nano"},{"issue":"5","key":"5115_CR15","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1016\/j.apsb.2025.03.016","volume":"15","author":"L Lin","year":"2025","unstructured":"Lin L, Fang Z, Liu G, Liu Y, Li Z, Pan D, et al. Prodrug-based combinational nanomedicine remodels lipid metabolism for reinforced ferroptosis and immune activation. Acta Pharm Sin B. 2025;15(5):2746\u201363.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"5115_CR16","doi-asserted-by":"publisher","first-page":"10060","DOI":"10.1038\/s41467-024-54469-7","volume":"15","author":"M Guan","year":"2024","unstructured":"Guan M, Cheng K, Xie X, Li Y, Ma M, Zhang B, et al. Regulating copper homeostasis of tumor cells to promote cuproptosis for enhancing breast cancer immunotherapy. Nat Commun. 2024;15(1):10060.","journal-title":"Nat Commun"},{"issue":"6","key":"5115_CR17","doi-asserted-by":"publisher","first-page":"e03530","DOI":"10.1002\/adhm.202503530","volume":"15","author":"K Deng","year":"2026","unstructured":"Deng K, Gao W, Wen Y, Huang J, Li X, Yang X, et al. A functional nanocomposite tri-activates cuproptosis, ferroptosis, and mitophagy death pathway to oppose malignancies. Adv Healthc Mater. 2026;15(6):e03530.","journal-title":"Adv Healthc Mater"},{"issue":"13","key":"5115_CR18","doi-asserted-by":"publisher","first-page":"6282","DOI":"10.1039\/D5CS00083A","volume":"54","author":"L Mao","year":"2025","unstructured":"Mao L, Lu J, Wen X, Song Z, Sun C, Zhao Y, et al. Cuproptosis: mechanisms and nanotherapeutic strategies in cancer and beyond. Chem Soc Rev. 2025;54(13):6282\u2013334.","journal-title":"Chem Soc Rev"},{"issue":"8","key":"5115_CR19","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/s41556-025-01722-w","volume":"27","author":"H Zhang","year":"2025","unstructured":"Zhang H, Ma J, Hou C, Luo X, Zhu S, Peng Y, et al. A ROS-mediated oxidation-O-GlcNAcylation cascade governs ferroptosis. Nat Cell Biol. 2025;27(8):1288\u2013300.","journal-title":"Nat Cell Biol"},{"key":"5115_CR20","doi-asserted-by":"publisher","first-page":"122701","DOI":"10.1016\/j.biomaterials.2024.122701","volume":"311","author":"L Huang","year":"2024","unstructured":"Huang L, Zhu J, Wu G, Xiong W, Feng J, Yan C, et al. A strategy of adding fuel to the flames enables a self-accelerating cycle of ferroptosis-cuproptosis for potent antitumor therapy. Biomaterials. 2024;311:122701.","journal-title":"Biomaterials"},{"key":"5115_CR21","doi-asserted-by":"publisher","first-page":"123538","DOI":"10.1016\/j.biomaterials.2025.123538","volume":"325","author":"H Zhi","year":"2026","unstructured":"Zhi H, Yin W, Chen S, Zhang X, Yang Z, Man F, et al. Lactate metabolism regulating nanosystem synergizes cuproptosis and ferroptosis to enhance cancer immunotherapy. Biomaterials. 2026;325:123538.","journal-title":"Biomaterials"},{"issue":"5","key":"5115_CR22","doi-asserted-by":"publisher","first-page":"e14995","DOI":"10.1002\/adfm.202514995","volume":"36","author":"X Cheng","year":"2026","unstructured":"Cheng X, Yin Y, Fang Y, Zhou X, Guo H, Fan D, et al. Breaking the depth barrier: dual-activated radical storm from a natural product-based nanoplatform for spatiotemporally controlled deep tumor sonodynamic therapy. Adv Funct Mater. 2026;36(5):e14995.","journal-title":"Adv Funct Mater"},{"issue":"23","key":"5115_CR23","doi-asserted-by":"publisher","first-page":"2402516","DOI":"10.1002\/advs.202402516","volume":"11","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Niu X, Ding C, Lin Y, Fang W, Yan L, et al. Carrier-free self-assembly nano-sonosensitizers for sonodynamic-amplified cuproptosis-ferroptosis in glioblastoma therapy. Adv Sci (Weinh). 2024;11(23):2402516.","journal-title":"Adv Sci (Weinh)"},{"key":"5115_CR24","doi-asserted-by":"publisher","first-page":"100996","DOI":"10.1016\/j.mtbio.2024.100996","volume":"25","author":"L Ye","year":"2024","unstructured":"Ye L, Yu C, Xia J, Ni K, Zhang Y, Ying X, et al. Multifunctional nanomaterials via cell cuproptosis and oxidative stress for treating osteosarcoma and OS-induced bone destruction. Mater Today Bio. 2024;25:100996.","journal-title":"Mater Today Bio"},{"issue":"44","key":"5115_CR25","doi-asserted-by":"publisher","first-page":"38440","DOI":"10.1021\/acsnano.5c11335","volume":"19","author":"W Zhu","year":"2025","unstructured":"Zhu W, Sun Y, Xu K, Xie C, Yang M, Ye Y, et al. Ultrasmall manganese-doped TiO2\u2013x overcomes the efficacy-safety dilemma of sonodynamic therapy via tumor microenvironment-responsive reactive oxygen species amplification and clearance. ACS Nano. 2025;19(44):38440\u201356.","journal-title":"ACS Nano"},{"issue":"5","key":"5115_CR26","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41416-024-02898-y","volume":"132","author":"VG Collins","year":"2025","unstructured":"Collins VG, Hutton D, Hossain-Ibrahim K, Joseph J, Banerjee S. The abscopal effects of sonodynamic therapy in cancer. Br J Cancer. 2025;132(5):409\u201320.","journal-title":"Br J Cancer"},{"issue":"30","key":"5115_CR27","first-page":"19756","volume":"18","author":"S Sun","year":"2024","unstructured":"Sun S, Huang X, Yang N, Lei H, Pei Z, Han Z, et al. Fluorinated titanium oxide (TiO2\u2013xFx) nanospindles as ultrasound-triggered pyroptosis inducers to boost sonodynamic immunotherapy. ACS Nano. 2024;18(30):19756\u201370.","journal-title":"ACS Nano"},{"issue":"16","key":"5115_CR28","doi-asserted-by":"publisher","first-page":"8151","DOI":"10.1039\/D3NR06588J","volume":"16","author":"N Li","year":"2024","unstructured":"Li N, Li L, Qiu Y, Liu X, Zhang J, Gao Y, et al. Hollow cubic CuSe@CdS with tunable size for plasmon-induced Vis-NIR driven photocatalytic properties. Nanoscale. 2024;16(16):8151\u201361.","journal-title":"Nanoscale"},{"issue":"7","key":"5115_CR29","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1080\/15548627.2023.2165323","volume":"19","author":"Q Xue","year":"2023","unstructured":"Xue Q, Yan D, Chen X, Li X, Kang R, Klionsky DJ, et al. Copper-dependent autophagic degradation of GPX4 drives ferroptosis. Autophagy. 2023;19(7):1982\u201396.","journal-title":"Autophagy"},{"key":"5115_CR30","doi-asserted-by":"publisher","first-page":"122252","DOI":"10.1016\/j.biomaterials.2023.122252","volume":"301","author":"X Qiao","year":"2023","unstructured":"Qiao X, Liang J, Qiu L, Feng W, Cheng G, Chen Y, et al. Ultrasound-activated nanosonosensitizer for oxygen\/sulfate dual-radical nanotherapy. Biomaterials. 2023;301:122252.","journal-title":"Biomaterials"},{"key":"5115_CR31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.actbio.2023.02.011","volume":"160","author":"X Feng","year":"2023","unstructured":"Feng X, Lin T, Chen D, Li Z, Yang Q, Tian H, et al. Mitochondria-associated ER stress evokes immunogenic cell death through the ROS-PERK-eIF2\u03b1 pathway under PTT\/CDT combined therapy. Acta Biomater. 2023;160:211\u201324.","journal-title":"Acta Biomater"},{"issue":"3","key":"5115_CR32","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3390\/ma16030960","volume":"16","author":"Z Chen","year":"2023","unstructured":"Chen Z, Zhu X, Xiong J, Wen Z, Cheng G. A p-n junction by coupling amine-enriched brookite-TiO2 nanorods with CuxS nanoparticles for improved photocatalytic CO2 reduction. Mater (Basel). 2023;16(3):960.","journal-title":"Mater (Basel)"},{"issue":"43","key":"5115_CR33","doi-asserted-by":"publisher","first-page":"e2302758","DOI":"10.1002\/smll.202302758","volume":"19","author":"Z Chen","year":"2023","unstructured":"Chen Z, Li Z, Huang H, Shen G, Ren Y, Mao X, et al. Cancer immunotherapy based on cell membrane-coated nanocomposites augmenting cGAS\/STING activation by efferocytosis blockade. Small. 2023;19(43):e2302758.","journal-title":"Small"},{"key":"5115_CR34","doi-asserted-by":"publisher","first-page":"136428","DOI":"10.1016\/j.cej.2022.136428","volume":"443","author":"W Guo","year":"2022","unstructured":"Guo W, Chen Z, Li Z, Huang H, Ren Y, Zhao B, et al. Improved immunotherapy for gastric cancer by nanocomposites with capability of triggering dual-damage of nuclear\/mitochondrial DNA and cGAS\/STING-mediated innate immunity. Chem Eng J. 2022;443:136428.","journal-title":"Chem Eng J"},{"key":"5115_CR35","doi-asserted-by":"publisher","first-page":"140868","DOI":"10.1016\/j.cej.2022.140868","volume":"455","author":"W Guo","year":"2023","unstructured":"Guo W, Chen Z, Li Z, Huang H, Ren Y, Li Z, et al. Cancer cell membrane biomimetic mesoporous silica nanotheranostics for enhanced ferroptosis-mediated immuogenic cell death on gastric cancer. Chem Eng J. 2023;455:140868.","journal-title":"Chem Eng J"},{"issue":"14","key":"5115_CR36","doi-asserted-by":"publisher","first-page":"7057","DOI":"10.7150\/thno.60427","volume":"11","author":"T Xiao","year":"2021","unstructured":"Xiao T, Hu W, Fan Y, Shen M, Shi X. Macrophage-mediated tumor homing of hyaluronic acid nanogels loaded with polypyrrole and anticancer drug for targeted combinational photothermo-chemotherapy. Theranostics. 2021;11(14):7057\u201371.","journal-title":"Theranostics"},{"issue":"1","key":"5115_CR37","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41392-025-02253-4","volume":"10","author":"X Xu","year":"2025","unstructured":"Xu X, Pang Y, Fan X. Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances. Signal Transduct Target Ther. 2025;10(1):190.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"5115_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41571-020-0408-9","volume":"18","author":"A Drilon","year":"2021","unstructured":"Drilon A, Jenkins C, Iyer S, Schoenfeld A, Keddy C, Davare MA. ROS1-dependent cancers: biology, diagnostics and therapeutics. Nat Rev Clin Oncol. 2021;18(1):35\u201355.","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"5115_CR39","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41573-024-00979-4","volume":"23","author":"C Glorieux","year":"2024","unstructured":"Glorieux C, Liu S, Trachootham D, Huang P. Targeting ROS in cancer: rationale and strategies. Nat Rev Drug Discov. 2024;23(8):583\u2013606.","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"5115_CR40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","volume":"19","author":"JP Friedmann Angeli","year":"2019","unstructured":"Friedmann Angeli JP, Krysko DV, Conrad M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer. 2019;19(7):405\u201314.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"5115_CR41","doi-asserted-by":"publisher","first-page":"10024","DOI":"10.1021\/acsnano.5c22255","volume":"20","author":"C Yu","year":"2026","unstructured":"Yu C, Chen D, Feng L, Zang P, He G, Liu J, et al. Piezocatalytic nanoplatform drives Mg2+-release-amplified ferroptosis-immune synergy for tumor microenvironment reprogramming. ACS Nano. 2026;20(12):10024\u201342.","journal-title":"ACS Nano"},{"issue":"1","key":"5115_CR42","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s40820-025-01862-6","volume":"18","author":"X Wei","year":"2026","unstructured":"Wei X, Jiang Y, Chenwu F, Li Z, Wan J, Li Z, et al. Synergistic ferroptosis-immunotherapy nanoplatforms: multidimensional engineering for tumor microenvironment remodeling and therapeutic optimization. Nano Micro Lett. 2026;18(1):56.","journal-title":"Nano Micro Lett"},{"issue":"6","key":"5115_CR43","doi-asserted-by":"publisher","first-page":"9938","DOI":"10.1021\/acsnano.2c04630","volume":"16","author":"M Zhang","year":"2022","unstructured":"Zhang M, Yang D, Dong C, Huang H, Feng G, Chen Q, et al. Two-dimensional MXene-originated in situ nanosonosensitizer generation for augmented and synergistic sonodynamic tumor nanotherapy. ACS Nano. 2022;16(6):9938\u201352.","journal-title":"ACS Nano"},{"issue":"19","key":"5115_CR44","doi-asserted-by":"publisher","first-page":"e2500652","DOI":"10.1002\/advs.202500652","volume":"12","author":"R Cheng","year":"2025","unstructured":"Cheng R, Li Z, Luo W, Chen H, Deng T, Gong Z, et al. A copper-based photothermal-responsive nanoplatform reprograms tumor immunogenicity via self-amplified cuproptosis for synergistic cancer therapy. Adv Sci (Weinh). 2025;12(19):e2500652.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"5115_CR45","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","volume":"7","author":"L Chen","year":"2022","unstructured":"Chen L, Min J, Wang F. Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther. 2022;7(1):378.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"5115_CR46","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12943-020-01247-w","volume":"19","author":"Y Wang","year":"2020","unstructured":"Wang Y, Luo J, Alu A, Han X, Wei Y, Wei X. cGAS-STING pathway in cancer biotherapy. Mol Cancer. 2020;19(1):136.","journal-title":"Mol Cancer"},{"issue":"12","key":"5115_CR47","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s43018-022-00468-w","volume":"3","author":"N Samson","year":"2022","unstructured":"Samson N, Ablasser A. The cGAS-STING pathway and cancer. Nat Cancer. 2022;3(12):1452\u201363.","journal-title":"Nat Cancer"},{"issue":"5","key":"5115_CR48","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41568-024-00674-x","volume":"24","author":"P Meier","year":"2024","unstructured":"Meier P, Legrand AJ, Adam D, Silke J. Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity. Nat Rev Cancer. 2024;24(5):299\u2013315.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"5115_CR49","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1016\/j.apsb.2025.06.014","volume":"15","author":"H Yao","year":"2025","unstructured":"Yao H, He Q, Wei S, Xiang L, Luo Y, Huang C, et al. Targeted inhibition of macrophage STING signaling alleviates inflammatory injury and ventricular remodeling in acute myocardial infarction. Acta Pharm Sin B. 2025;15(8):4030\u201346.","journal-title":"Acta Pharm Sin B"},{"issue":"6","key":"5115_CR50","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1161\/ATVBAHA.123.320612","volume":"44","author":"X Fan","year":"2024","unstructured":"Fan X, Han J, Zhong L, Zheng W, Shao R, Zhang Y, et al. Macrophage-derived GSDMD plays an essential role in atherosclerosis and cross talk between macrophages via the mitochondria-STING-IRF3\/NF-\u03baB axis. Arterioscler Thromb Vasc Biol. 2024;44(6):1365\u201378.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"5115_CR51","doi-asserted-by":"publisher","first-page":"e009473","DOI":"10.1136\/jitc-2024-009473","volume":"12","author":"Z Li","year":"2024","unstructured":"Li Z, Li M, Yang L, Chen J, Ye Q, Qian W, et al. Oncolytic vaccinia virus armed with anti-CD47 nanobody elicit potent antitumor effects on multiple tumor models via enhancing innate and adoptive immunity. J Immunother Cancer. 2024;12(12):e009473.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"5115_CR52","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12943-025-02258-1","volume":"24","author":"M Wan","year":"2025","unstructured":"Wan M, Pan S, Shan B, Diao H, Jin H, Wang Z, et al. Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment. Mol Cancer. 2025;24(1):61.","journal-title":"Mol Cancer"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-05115-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-05115-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-05115-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:02:25Z","timestamp":1790791345000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-05115-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,27]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5115"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-05115-5","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,27]]},"assertion":[{"value":"15 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The approval of the study was obtained from Institution Animal Ethics Committee of the Ethics Committee of Guangzhou Miles Biosciences (IACUC Issue No. MIS2026012).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"915"}}